Pay vs Performance Disclosure - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
| | Year | | | Summary Compensation Table Total for First PEO ($)(1)(2) | | | Summary Compensation Table Total for Second PEO ($)(1)(2) | | | Compensation Actually Paid to First PEO ($)(1)(3) | | | Compensation Actually Paid to Second PEO ($)(1)(3) | | | Average Summary Compensation Table Total for Non-PEO NEOs ($)(1)(4) | | | Average Compensation Actually Paid to Non-PEO NEOs ($)(1)(3) | | | Value of Initial Fixed $100 Investment Based On: | | | Net Income ($ Millions)(7) | | | Adjusted EBITDA ($ Millions)(8) | | |||
| | Total Shareholder Return ($)(5) | | | Peer Group Total Shareholder Return ($)(6) | | |||||||||||||||||||||||||||
| | 2025 | | | | | | 10,233,134 | | | | | | 24,042,695 | | | 2,291,973 | | | 2,819,180 | | | 160 | | | 142 | | | 177.7 | | | 332.6 | |
| | 2024 | | | | | | 7,418,653 | | | | | | 17,304,280 | | | 1,833,095 | | | 3,312,728 | | | 107 | | | 134 | | | 109.9 | | | 293.4 | |
| | 2023 | | | | | | 6,721,355 | | | | | | 7,642,078 | | | 1,954,108 | | | 2,094,025 | | | 80 | | | 123 | | | (154.1) | | | 272.0 | |
| | 2022 | | | | | | 7,028,222 | | | | | | 3,969,021 | | | 2,658,920 | | | 678,130 | | | 70 | | | 106 | | | 241.2 | | | 231.2 | |
| | 2021 | | | 4,736,187 | | | 8,420,877 | | | 3,227,659 | | | 10,028,492 | | | 2,615,880 | | | 2,711,700 | | | 84 | | | 127 | | | 66.5 | | | 434.2 | |
(1)
James P. Hallett was our PEO through March 31, 2021 (First PEO), and Peter J. Kelly became our PEO effective April 1, 2021 (Second PEO). Mr. Kelly was our PEO in 2022, 2023, 2024 and 2025. The Non-PEO NEOs included in these columns reflect the following:
•
2025: Bradley P. Herring; Brad S. Lakhia; James P. Coyle; Charles S. Coleman; and William C. Mitchell.
•
2024: Brad S. Lakhia; James P. Coyle; Charles S. Coleman; William C. Mitchell; and Sriram Subrahmanyam.
•
2023: Brad S. Lakhia; Scott A. Anderson; James P. Coyle; Sriram Subrahmanyam; James E. Money; and Justin T. Davis.
•
2022: Eric M. Loughmiller; James P. Hallett; James P. Coyle; Sriram Subrahmanyam; John C. Hammer; and Thomas J. Fisher.
•
2021: Eric M. Loughmiller; John C. Hammer; Justin T. Davis; and James P. Coyle.
(2)
Amounts reflect the total compensation for our PEOs, as reported in the Summary Compensation Table for the applicable fiscal year.
(3)
Amounts reflect the CAP to our PEOs and the average CAP to our Non-PEO NEOs, as computed in accordance with Item 402(v). Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. As provided in Item 402(v), the adjustments in the table below were made to our PEO’s and to the average Non-PEO NEO’s total compensation reported in the Summary Compensation Table for 2025 to determine the compensation actually paid to our PEO and the average compensation actually paid to Non-PEO NEOs for 2025 for purposes of this disclosure.
| Summary Compensation Table (“SCT”) Total for PEO and Non-PEO NEOs | | | 2025 PEO | | | 2025 Non-PEO NEOs | |
| SCT Total | | | $10,233,134 | | | $2,291,973 | |
| Adjustments for stock awards and option awards | | | | | | | |
| (Deduct): Aggregate value for stock awards and option awards included in SCT Total for the covered fiscal year | | | $(7,494,007) | | | $(1,252,706) | |
| Add: Fair value at year end of awards granted during the covered fiscal year that were outstanding and unvested at the covered fiscal year end | | | $10,951,360 | | | $1,778,676 | |
| Add (Deduct): Year-over-year change in fair value at covered fiscal year end of awards granted in any prior fiscal year that were outstanding and unvested at the covered fiscal year end | | | $8,753,768 | | | $687,039 | |
| Add: Vesting date fair value of awards granted and vested during the covered fiscal year | | | $89,216 | | | | |
| Add (Deduct): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during the covered fiscal year | | | $1,509,224 | | | $112,215 | |
| (Deduct): Fair value at end of prior fiscal year of awards granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year | | | | | | $(798,017) | |
| Add: Dividends or other earnings paid on awards in the covered fiscal year prior to vesting if not otherwise included in the SCT Total for the covered fiscal year | | | | | | | |
| CAP Amounts (as calculated) | | | $24,042,695 | | | $2,819,180 | |
(4)
Amounts reflect the average compensation for our non-PEO NEOs, as reported in the Summary Compensation Table for the applicable fiscal year.
(5)
The amounts in this column assume the investment of $100 on December 31, 2020 in the Company’s common stock and reinvestment of all dividends since that date.
(6)
The amounts in this column assume the investment of $100 on December 31, 2020 in the S&P SmallCap 600 Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2025 Annual Report on Form 10-K.
(7)
Amounts reflect the Company’s net income as reported in the Company’s audited financial statements for the applicable year.
(8)
Adjusted EBITDA (a non-GAAP measure), as defined on page 33, was selected as the 2025 “Company-Selected Measure” as defined in Item 402(v).
(1)
James P. Hallett was our PEO through March 31, 2021 (First PEO), and Peter J. Kelly became our PEO effective April 1, 2021 (Second PEO). Mr. Kelly was our PEO in 2022, 2023, 2024 and 2025. The Non-PEO NEOs included in these columns reflect the following:
•
2025: Bradley P. Herring; Brad S. Lakhia; James P. Coyle; Charles S. Coleman; and William C. Mitchell.
•
2024: Brad S. Lakhia; James P. Coyle; Charles S. Coleman; William C. Mitchell; and Sriram Subrahmanyam.
•
2023: Brad S. Lakhia; Scott A. Anderson; James P. Coyle; Sriram Subrahmanyam; James E. Money; and Justin T. Davis.
•
2022: Eric M. Loughmiller; James P. Hallett; James P. Coyle; Sriram Subrahmanyam; John C. Hammer; and Thomas J. Fisher.
•
2021: Eric M. Loughmiller; John C. Hammer; Justin T. Davis; and James P. Coyle.
(6)
The amounts in this column assume the investment of $100 on December 31, 2020 in the S&P SmallCap 600 Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2025 Annual Report on Form 10-K.
(3)
Amounts reflect the CAP to our PEOs and the average CAP to our Non-PEO NEOs, as computed in accordance with Item 402(v). Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. As provided in Item 402(v), the adjustments in the table below were made to our PEO’s and to the average Non-PEO NEO’s total compensation reported in the Summary Compensation Table for 2025 to determine the compensation actually paid to our PEO and the average compensation actually paid to Non-PEO NEOs for 2025 for purposes of this disclosure.
| Summary Compensation Table (“SCT”) Total for PEO and Non-PEO NEOs | | | 2025 PEO | | | 2025 Non-PEO NEOs | |
| SCT Total | | | $10,233,134 | | | $2,291,973 | |
| Adjustments for stock awards and option awards | | | | | | | |
| (Deduct): Aggregate value for stock awards and option awards included in SCT Total for the covered fiscal year | | | $(7,494,007) | | | $(1,252,706) | |
| Add: Fair value at year end of awards granted during the covered fiscal year that were outstanding and unvested at the covered fiscal year end | | | $10,951,360 | | | $1,778,676 | |
| Add (Deduct): Year-over-year change in fair value at covered fiscal year end of awards granted in any prior fiscal year that were outstanding and unvested at the covered fiscal year end | | | $8,753,768 | | | $687,039 | |
| Add: Vesting date fair value of awards granted and vested during the covered fiscal year | | | $89,216 | | | | |
| Add (Deduct): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during the covered fiscal year | | | $1,509,224 | | | $112,215 | |
| (Deduct): Fair value at end of prior fiscal year of awards granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year | | | | | | $(798,017) | |
| Add: Dividends or other earnings paid on awards in the covered fiscal year prior to vesting if not otherwise included in the SCT Total for the covered fiscal year | | | | | | | |
| CAP Amounts (as calculated) | | | $24,042,695 | | | $2,819,180 | |
(3)
Amounts reflect the CAP to our PEOs and the average CAP to our Non-PEO NEOs, as computed in accordance with Item 402(v). Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. As provided in Item 402(v), the adjustments in the table below were made to our PEO’s and to the average Non-PEO NEO’s total compensation reported in the Summary Compensation Table for 2025 to determine the compensation actually paid to our PEO and the average compensation actually paid to Non-PEO NEOs for 2025 for purposes of this disclosure.
| Summary Compensation Table (“SCT”) Total for PEO and Non-PEO NEOs | | | 2025 PEO | | | 2025 Non-PEO NEOs | |
| SCT Total | | | $10,233,134 | | | $2,291,973 | |
| Adjustments for stock awards and option awards | | | | | | | |
| (Deduct): Aggregate value for stock awards and option awards included in SCT Total for the covered fiscal year | | | $(7,494,007) | | | $(1,252,706) | |
| Add: Fair value at year end of awards granted during the covered fiscal year that were outstanding and unvested at the covered fiscal year end | | | $10,951,360 | | | $1,778,676 | |
| Add (Deduct): Year-over-year change in fair value at covered fiscal year end of awards granted in any prior fiscal year that were outstanding and unvested at the covered fiscal year end | | | $8,753,768 | | | $687,039 | |
| Add: Vesting date fair value of awards granted and vested during the covered fiscal year | | | $89,216 | | | | |
| Add (Deduct): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during the covered fiscal year | | | $1,509,224 | | | $112,215 | |
| (Deduct): Fair value at end of prior fiscal year of awards granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year | | | | | | $(798,017) | |
| Add: Dividends or other earnings paid on awards in the covered fiscal year prior to vesting if not otherwise included in the SCT Total for the covered fiscal year | | | | | | | |
| CAP Amounts (as calculated) | | | $24,042,695 | | | $2,819,180 | |
The following charts set forth the relationship between our PEO’s and Non-PEO NEOs’ CAP to (i) our TSR and S&P SmallCap 600 Index TSR, (ii) our net income, and (iii) our Adjusted EBITDA, over the five-year period from 2021 through 2025, each as set forth in the table above.*
CAP vs. TSR
![[MISSING IMAGE: bc_tsr-pn.jpg]](bc_tsr-pn.jpg)
* PEO CAP for 2021 reflects the aggregate average 2021 CAP for Messrs. Kelly and Hallett, who each served as a PEO during a portion of 2021.
The following charts set forth the relationship between our PEO’s and Non-PEO NEOs’ CAP to (i) our TSR and S&P SmallCap 600 Index TSR, (ii) our net income, and (iii) our Adjusted EBITDA, over the five-year period from 2021 through 2025, each as set forth in the table above.*
CAP vs. Net Income
![[MISSING IMAGE: bc_netincome-pn.jpg]](bc_netincome-pn.jpg)
* PEO CAP for 2021 reflects the aggregate average 2021 CAP for Messrs. Kelly and Hallett, who each served as a PEO during a portion of 2021.
The following charts set forth the relationship between our PEO’s and Non-PEO NEOs’ CAP to (i) our TSR and S&P SmallCap 600 Index TSR, (ii) our net income, and (iii) our Adjusted EBITDA, over the five-year period from 2021 through 2025, each as set forth in the table above.*
CAP vs. Adjusted EBITDA
![[MISSING IMAGE: bc_ebitda-pn.jpg]](bc_ebitda-pn.jpg)
* PEO CAP for 2021 reflects the aggregate average 2021 CAP for Messrs. Kelly and Hallett, who each served as a PEO during a portion of 2021.
The following charts set forth the relationship between our PEO’s and Non-PEO NEOs’ CAP to (i) our TSR and S&P SmallCap 600 Index TSR, (ii) our net income, and (iii) our Adjusted EBITDA, over the five-year period from 2021 through 2025, each as set forth in the table above.*
CAP vs. TSR
* PEO CAP for 2021 reflects the aggregate average 2021 CAP for Messrs. Kelly and Hallett, who each served as a PEO during a portion of 2021.
In accordance with Item 402(v) requirements, we are providing the following unranked list of the financial performance measures that the Company considers to have been most important in linking the CAP to the PEO and Non-PEO NEOs in 2025 as set forth in the table above and Company performance:
•
Adjusted EBITDA
•
Stock Price
•
Relative Total Shareholder Return
(8)
Adjusted EBITDA (a non-GAAP measure), as defined on page 33, was selected as the 2025 “Company-Selected Measure” as defined in Item 402(v).